CORRECTION article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1637511

This article is part of the Research TopicCholesterol, inflammation and immunityView all 7 articles

Correction: Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells

Provisionally accepted
Valeria Saar-KovrovValeria Saar-Kovrov1Aleksandra (Ola) PawlowskaAleksandra (Ola) Pawlowska1Adrien GuillotAdrien Guillot2Marion GijbelsMarion Gijbels1,3,4Judith SluimerJudith Sluimer1,5Lieve TemmermanLieve Temmerman1Pieter GoossensPieter Goossens1Barend Me MeesBarend Me Mees6Frank TackeFrank Tacke2Vera JankowskiVera Jankowski7Joachim JankowskiJoachim Jankowski7Marjo DonnersMarjo Donners1Erik A.L. BiessenErik A.L. Biessen1,7*
  • 1School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
  • 2Charite - Universitatsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany
  • 3Maastricht University GROW - Research Institute for Oncology and Reproduction, Maastricht, Netherlands
  • 4Amsterdam UMC Locatie AMC Department of Medical Biochemistry, Amsterdam, Netherlands
  • 5The University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom
  • 6Maastricht Universitair Medisch Centrum+ Afdeling Vaatchirurgie, Maastricht, Netherlands
  • 7Rheinisch-Westfalische Technische Hochschule Aachen, Aachen, Germany

This article is a correction to:

  1. Plaque Protein Carbamylation Is Associated with Atherosclerosis Progression and Uremia and Accumulates in Foam Cells

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

In the published article, there was an error in the Funding statement. The correct funding should be:This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 764474 (CaReSyAn). VJankowski and JJankowski are funded by the German Research Foundation (DFG) through the Transregional Collaborative Research Center (TRR 219; Project ID 322900939), (subproject S-03), (INST 948/4S-1); CRU 5011 project number 445703531, Cost-Action CA 21165, IZKF Multiorgan complexity in Friedreich Ataxia, and Phase Transition in Disease 1-1), ERA-PerMed (ERA-PERMED2022-202-KidneySign).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: Atherosclerosis, Macrophages, Foam Cells, Carbamylation, kidney disease

Received: 29 May 2025; Accepted: 05 Jun 2025.

Copyright: © 2025 Saar-Kovrov, Pawlowska, Guillot, Gijbels, Sluimer, Temmerman, Goossens, Mees, Tacke, Jankowski, Jankowski, Donners and Biessen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Erik A.L. Biessen, School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material